About 100 reports

In Japan, Taisho Pharmaceutical developed an anti-inflammatory analgesic patch formulation, LOQOA Tape, for the treatment of osteoarthritis pain and inflammation.

  • Cell Therapy
  • Hospital
  • Regenerative Medicine
  • Arthrex, Inc.
  • Stryker Corporation

In Japan, the Taisho Pharmaceutical developed anti-inflammatory analgesic patch formulation LOQOA Tape for the treatment of osteoarthritis pain and inflammation.

  • Cell Therapy
  • Acelity L.P. Inc.
  • Arthrex, Inc.
  • Ethicon, Inc.
  • Medtronic, Inc.

THE SERVICE INCLUDES HUMANIZED PD-##, PD-L##, CTLA-##, OX##, CD##, PD-##/ PD-L##, AND PD-##/ CTLA-## TARGETS.

  • Cell Therapy
  • Abzena plc
  • Biologics, Inc.
  • Horizon Discovery
  • Merck & Co., Inc.

## Prostate Cancer ## Renal Failure ## Soft Tissue Injury ## Cancer ## Coronary Artery Disease ## Deep Vein Thrombosis ## Hepatocellular Carcinoma ## Liver Cancer ## Pancreatic Cancer ## Peripheral Artery Disease

  • Cell Therapy
  • Drug Delivery
  • Pancreatic Cancer
  • Transdermal Delivery
  • AngioDynamics, Inc.

## ## ## ## ## ## ## ## MallInckrodt Plc ## ## ## ## ## ## ## ## Syneos Health Inc ## ## ## ## ## ## ## ## Sun Pharmaceutical Industries Ltd ## ## ## ## ## ## ## ## Pfizer Inc Noveome Biotherapeutics Inc Fresenius SE & Co KGaA Fibrocell Science Inc Bayer AG ##

  • Cell Therapy
  • Clinical Trial
  • Therapy
  • World
  • MediWound Ltd.

Invectys SA is developing INVAC-##.

  • Cancer
  • Cell Therapy
  • Lung Cancer
  • Therapy
  • Geron Corporation

The prominent features of this report are - ##.

  • Cell Therapy
  • Hospital
  • World
  • Product Initiative
  • Novartis AG

NF-kappaB decoy differs from existing analgesics, because it exerts its analgesic effect by inhibiting the causative agent.

  • Cell Therapy
  • Polyclonal Antibody
  • Japan
  • Company
  • AnGes MG, Inc.

The prominent features of this report are - ##.

  • Cell Therapy
  • Clinical Trial
  • Pharmaceutical
  • Wound Care
  • World
  • DIABETIC FOOT ULCERS - PIPELINE BY MALLINCKRODT PLC, H2 2018
  • STEMPEUCEL - DRUG PROFILE

Until now, most of the medications prescribed for diabetic neuropathy have largely been analgesics aimed for pain relief.

  • Cell Therapy
  • Chronic Disease
  • Type 2 Diabetes
  • Wound Care
  • ViroMed Co., Ltd.

NF-kappaB decoy differs from existing analgesics, because it exerts its analgesic effect by inhibiting the causative agent.

  • Cell Therapy
  • Polyclonal Antibody
  • Japan
  • Company
  • AnGes MG, Inc.

The opioid epidemic, which stems in part from prescribing opiate analgesics for outpatient procedures, makes it imperative that we find new analgesics devoid of abuse potential.

  • Cell Therapy
  • Depression
  • Therapy
  • United States
  • VistaGen Therapeutics, Inc.

GDCT ID is the unique ID of GlobalData' s Pharma Intelligence Center clinical trial database Clinical Trial profile. ## Trial Title Official Title Trial Identifier Secondary ID(s) Therapy Area Indication(s) Trial Status Trial Phase Study Type Drug(s)/ Molecule(s) Sponsor(s) Estimated

  • Cell Therapy
  • Clinical Trial
  • Drug Development
  • World
  • Product Initiative
  • STEMPEUCEL - DRUG PROFILE

THE DRUG CANDIDATES POSSESS ANALGESIC ACTIVITY.

  • Cell Therapy
  • United States
  • Company
  • Product Initiative
  • Can-Fite BioPharma Ltd.
  • STEMPEUCEL - DRUG PROFILE

Until now, most of the medications prescribed for diabetic neuropathy have largely been analgesics aimed for pain relief.

  • Cell Therapy
  • Pharmaceutical
  • Type 2 Diabetes
  • Wound Care
  • ProMetic Life Sciences Inc.

The finance was provided by current investors of Argos Therapeutics and one new investor.

  • Cell Therapy
  • Pharmaceutical
  • South Korea
  • M&A
  • Green Cross
  • LICENSING AGREEMENTS
  • LICENSING AGREEMENTS

Clevegen targets a cell surface receptor called Clever-##.

  • Cell Therapy
  • Switzerland
  • United States
  • Company
  • Selexis SA

## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## Merck & Co Inc Cesca Therapeutics Inc Blood and Tissue Bank Blackmores Ltd BioStar Pharmaceuticals Inc ## ## ## ## ## ## ## ## ## ## ## ##

  • Cell Therapy
  • Clinical Trial
  • World
  • Product Initiative
  • Novartis AG

Its therapeutic areas include anti hypertensive, anti anginal, anti emetic, expectorant, decongestants, proton pump inhibitors and analgesic, among others.

  • Cell Therapy
  • Pharmaceutical
  • Therapy
  • United States
  • Intrexon Corporation
  • STEMPEUCEL - DRUG PROFILE

It offers anti-inflammatory and analgesic therapies for osteoarthritis.

  • Cell Therapy
  • United States
  • World
  • Company
  • Product Initiative

Naproxen, the anti-inflammatory metabolite of naproxcinod, is a well characterized NSAID that exerts its anti-inflammatory, analgesic and antipyretic effects by non selectively inhibiting COX-## and COX-##.

  • Cell Therapy
  • Neurological Disorder
  • United States
  • Product Initiative
  • Sarepta Therapeutics, Inc.

## ## ## ## ## ## ## ## ## ## ## ## GlaxoSmithKline Plc Galera Therapeutics Inc Novartis AG ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## MallInckrodt Plc Jazz Pharmaceuticals Plc Eisai Co Ltd CD Pharma India Pvt Ltd Biotec Pharmacon ASA Sourc

  • Cell Therapy
  • Clinical Trial
  • Lymphoma
  • World
  • Product Initiative

It also offers analgesics and gastrointestinal products and immunotherapy and neonatal respiratory critical care therapies; active pharmaceutical ingredients (APIs) and external manufacturing services.

  • Cell Therapy
  • Therapy
  • United States
  • Product Initiative
  • Fibrocell Science, Inc.

The finance was provided by current investors of Argos Therapeutics and one new investor.

  • Cell Therapy
  • Pharmaceutical
  • South Korea
  • M&A
  • Green Cross

The prominent features of this report are - ##.

  • Cell Therapy
  • Neurology
  • Pharmaceutical
  • World
  • Product Initiative

Until now, most of the medications prescribed for diabetic neuropathy have largely been analgesics aimed for pain relief.

  • Cell Therapy
  • Gene Therapy
  • Regenerative Medicine
  • Therapy
  • AnGes MG, Inc.
  • LIVER CIRRHOSIS - PIPELINE BY INTERNATIONAL STEM CELL CORP, H2 2018

Day ##).

  • Cell Therapy
  • Digestive System Disorder
  • United States
  • Product Initiative
  • Galectin Therapeutics Inc.

The molecules developed by Companies in Phase II, Preclinical and Discovery stages are ##, ## and ## respectively.

  • Cell Therapy
  • United States
  • World
  • Product Initiative
  • MediciNova, Inc.

Int J Clin Exp ##.

  • Cell Therapy
  • Angion Biomedica Corp.
  • Astellas Pharma Inc.
  • AstraZeneca PLC
  • Eli Lilly & Co.

TUMOR REGRESSION WAS INDUCED BY MP## IN ONE LIVER AND ONE RENAL MODEL WITH OPTIMAL T/ C VALUES OF ##. ##% AND ##. ##%.

  • Cell Therapy
  • Medical Biotechnology
  • Therapy
  • United States
  • Product Initiative